AnalystsMartin Fan
Martin Fan's Stock Forecasts

Analyst Ranking
Top 5%
#249 out of 5502 analysts
Average Return
+57.1%
Win Rate
74%29 out of 39
Risk vs Reward
Poor
Good

Martin Fan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Oruka Therapeutics IncORKA
+575.48%$9.46$63.90
2025-05-15 -
2026-05-14
Buy
Aclaris Therapeutics IncACRS
+224.82%$1.41$4.58
2025-05-28 -
2026-05-27
Buy
Anaptysbio IncANAB
+202.90%$21.70$65.73
2025-05-01 -
2026-04-30
Buy
Oruka Therapeutics IncORKA
+192.37%$31.34$91.63
2026-01-13 -
2026-09-02
Buy
Anaptysbio IncANAB
+168.88%$20.37$54.77
2025-08-07 -
2026-08-06
Buy

Martin Fan Analyst Color

Get additional color on Martin Fan's coverage of popular stocks

Martin Fan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cartesian Therapeutics IncRNAC
6Buy$38.00+318.50%Reiterates
17 days ago
Immunic IncIMUX
1Buy$45.00+216.01%Initiates Coverage On
18 days ago
Fate Therapeutics IncFATE
1Buy$7.00+185.71%Reiterates
21 days ago
Zenas Biopharma IncZBIO
4Buy$45.00+35.83%Reiterates
21 days ago
First Tracks Biotherapeutics IncTRAX
2Buy$70.00+54.59%Maintains
22 days ago
Vor Biopharma IncVOR
4Hold$27.00+9.05%Maintains
22 days ago
Zura Bio LtdZURA
3Buy$22.00+288.01%Maintains
22 days ago
Oruka Therapeutics IncORKA
5Buy$165.00+80.07%Reiterates
24 days ago
Imagenebio IncIMA
2Sell$2.00-59.68%Reiterates
4 months ago
Nektar TherapeuticsNKTR
3Hold$80.00+9.98%Maintains
4 months ago
Artiva Biotherapeutics IncARTV
3Buy$40.00+253.67%Maintains
4 months ago
Aclaris Therapeutics IncACRS
3Buy$10.00+61.81%Maintains
4 months ago
Sana Biotechnology IncSANA
3Buy$7.00+79.95%Maintains
5 months ago
Anaptysbio IncANAB
6Buy$75.00+34.31%Maintains
6 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.